Phase 1 clinical trial of a novel proteasome inhibitor (NPI-0052) in patients with lymphomas and solid tumors Meeting Abstract
| Authors: | Kurzrock, R.; Hamlin, P.; Younes, A.; Hong, D.; Gordon, M.; Spear, M. A.; Palladino, M. A.; Lloyd, G. K.; Longenecker, A. M.; Neuteboom, S. T. C.; Cropp, G. F.; Hannah, A.; Aghajanian, C. |
| Abstract Title: | Phase 1 clinical trial of a novel proteasome inhibitor (NPI-0052) in patients with lymphomas and solid tumors |
| Meeting Title: | 49th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 110 |
| Issue: | 11 Pt. 2 |
| Meeting Dates: | 2007 Dec 8-11 |
| Meeting Location: | Atlanta, GA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2007-11-01 |
| Start Page: | 198B |
| Language: | English |
| ACCESSION: | WOS:000251101101275 |
| PROVIDER: | wos |
| PUBMED: | 18092370 |
| DOI: | 10.1182/blood.V110.11.4504.4504 |
| Notes: | --- - Meeting Abstract: 4504 - 49th Annual Meeting of the American-Society-of-Hematology - DEC 08-11, 2007 - Atlanta, GA - Part 2 - "Source: Wos" |
